Quarterly report pursuant to Section 13 or 15(d)

Revenue Disaggregation

v3.23.3
Revenue Disaggregation
 6 Months Ended
Sep. 30, 2023
Revenue from Contract with Customer [Abstract]  
Revenue Disaggregation

 

Note 10. Revenue Disaggregation

 

The Company generates revenues from products which are sold into the human and animal healthcare markets and to multiple geographic regions.

 

The following table presents the Company’s disaggregated revenues by revenue source:

                         
(In thousands)   Three Months Ended September 30,     Six Months Ended September 30,  
    2023     2022     2023     2022  
Human Care   $ 2,075     $ 2,447     $ 4,825     $ 4,615  
Animal Care     489       737       1,067       1,523  
Service and Royalty     167       147       266       1,176  
    $ 2,731     $ 3,331     $ 6,158     $ 7,314  

 

The following table shows the Company’s revenues by geographic region:

                         
    Three Months Ended September 30,     Six Months Ended September 30,  
(In thousands)   2023     2022     2023     2022  
United States   $ 590     $ 973     $ 1,396     $ 1,842  
Europe     1,201       1,170       2,271       2,012  
Asia     346       518       1,208       1,438  
Latin America     260       394       747       1,444  
Rest of the World     334       276       536       578  
Total   $ 2,731     $ 3,331     $ 6,158     $ 7,314  

 

The Company aligned the geographic regions reported in the Asia and Rest of World segments in fiscal year 2022 to conform to the current year presentation. For the three months ended September 30, 2022, the Company reclassified $188,000 from Rest of World to Asia and for the six months ended September 30, 2022, the Company reclassified $283,000 from Rest of World to Asia.